Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
We recently compiled a list of the 8 Best Wide Moat Stocks to Buy According to Analysts. In this article, we are going to ...
Pfizer's stock underperformed its healthcare peers since PFE topped out in late July 2024. Click here to find out why I ...
Pharmaceutical giant Pfizer ( PFE 2.73%) stands out in this context. The company currently offers a mouthwatering 5.7% ...
Pfizer purchased a stunning amount of radio ads as the company urges getting COVID-19 booster shots and flu vaccinations ...
A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical ...
Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug ...
Financial giants have made a conspicuous bearish move on Pfizer. Our analysis of options history for Pfizer PFE revealed ...
The stock's rise snapped a five-day losing streak.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback